Variable |  | ΔFita (in %) | P-value (LR-Testc) | Intraclass Correlation (in %) | ||
---|---|---|---|---|---|---|
Model | estimate | 95%-CIb | ||||
 | lower | upper | ||||
BP measurement during first 1.5Â years of disease | ||||||
 BP measured | logit | 28.2 |  < 0.0001 | 54.4 | 29.0 | 77.8 |
 Number of BP measurements | linear | 3.3 |  < 0.0001 | 18.0 | 7.0 | 39.1 |
 BP measured at least 3 times | logit | 13.8 |  < 0.0001 | 54.4 | 24.4 | 81.5 |
 ABPM | logit | 23.6 |  < 0.0001 | 79.7 | 40.3 | 95.8 |
 Basis diagnostic | logit | 24.4 |  < 0.0001 | 75.2 | 35.8 | 94.3 |
 Health Check-up | logit | 28.9 |  < 0.0001 | 61.1 | 33.2 | 83.2 |
Therapy during sample period | ||||||
 No medical therapy | logit | 21.8 |  < 0.0001 | 40.2 | 18.8 | 66.1 |
 Mono-therapy | logit | 3.8 |  < 0.0001 | 16.9 | 6.0 | 39.5 |
 Combination-therapy | logit | 10.4 |  < 0.0001 | 28.9 | 12.0 | 54.8 |
 Number of different drugs | linear | 2.8 |  < 0.0001 | 18.6 | 7.3 | 40.1 |
 Number of different APIs | linear | 4.1 |  < 0.0001 | 19.3 | 7.6 | 41.1 |
 Number of different ATCs | linear | 4.9 |  < 0.0001 | 20.6 | 8.2 | 43.1 |
 Number of different ACE inhibitors | linear | 1.5 |  < 0.0001 | 8.8 | 3.1 | 22.6 |
Outcome quality | ||||||
   < 140/90 mmHg (during the first year) | logit | 0.0 |  > 0.999 | 0.1 | 0.0 | 100 |
   < 140/90 mmHg (after one year) | logit | 0.0 | 0.92 | 1.7 | 0.0 | 11.2 |